Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization

There is insufficient evidence to support use of topical or systemic antimicrobial therapy for eradicating nasal or extra-nasal MRSA, and there is no demonstrated superiority of either topical and systemic therapy, or of combinations of these agents.

Abstract

There is insufficient evidence to support use of topical or systemic antimicrobial therapy for eradicating nasal or extra-nasal MRSA. There is no demonstrated superiority of either topical or systemic therapy, or of combinations of these agents. Potentially serious adverse events and development of antimicrobial resistance can result from therapy.